Sodium Citrate and Citric Acid Oral Solution USP

Manufacturer
American Health Packaging
Effective date
2024-07-16
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 21:08:30

Label at a glance#

ProductSodium Citrate and Citric Acid
Active ingredientSODIUM CITRATE, UNSPECIFIED FORM, ANHYDROUS CITRIC ACID
Label structure16 sections

Indications and uses

Sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contra...

Dosage and administration

Sodium Citrate and Citric Acid Oral Solution USP should be taken diluted in water, followed by additional water, if desired. SHAKE WELL BEFORE USING.

Storage and handling

Store at controlled room temperature, 20° to 25°C (68° to 77°F). Protect from freezing. Rx ONLY DO NOT USE IF SEAL IS BROKEN.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

A Sugar-Free Systemic Alkalizer

DESCRIPTION

DESCRIPTION SECTION

Sodium Citrate and Citric Acid Oral Solution USP is a stable and pleasant-tasting systemic alkalizer containing sodium citrate and citric acid in a sugar-free base. It is a nonparticulate neutralizing buffer.

Sodium Citrate and Citric Acid Oral Solution USP contains in each teaspoonful (5 mL):
SODIUM CITRATE Dihydrate 500 mg (0.34 Molar)
CITRIC ACID Monohydrate 334 mg (0.32 Molar)

Each mL contains 1 mEq sodium ion and is equivalent to 1 mEq bicarbonate (HCO 3).

Sodium citrate contains the following inactive ingredients: flavoring, polyethylene glycol, propylene glycol, purified water, sodium benzoate, and sorbitol solution.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Sodium citrate is absorbed and metabolized to sodium bicarbonate, thus acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of sodium citrate is excreted in the urine unchanged.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively.

Sodium Citrate and Citric Acid Oral Solution USP is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Patients on sodium-restricted diets or with severe renal impairment.

PRECAUTIONS

PRECAUTIONS SECTION

Sodium Citrate and Citric Acid Oral Solution USP should be used with caution by patients with low urinary output unless under the supervision of a physician. This product should not be administered concurrently with aluminum-based antacids. Patients should be directed to dilute adequately with water and preferably, to take each dose after meals to avoid saline laxative effect. Sodium salts should be used cautiously in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary edema, and toxemia of pregnancy. Periodic examinations and determinations of serum electrolytes, particularly serum bicarbonate level, should be carried out in those patients with renal disease in order to avoid these complications.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Sodium Citrate and Citric Acid Oral Solution USP is generally well tolerated, without any unpleasant side effects, when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of alkalosis, especially in the presence of hypocalcemia.

To report SUSPECTED ADVERSE REACTIONS, contact Pharmaceutical Associates, Inc. at 1-800-845-8210 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

OVERDOSAGE

OVERDOSAGE SECTION

Overdosage with sodium salts may cause diarrhea, nausea and vomiting, hypernoia, and convulsions.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Sodium Citrate and Citric Acid Oral Solution USP should be taken diluted in water, followed by additional water, if desired. SHAKE WELL BEFORE USING.

For Systemic Alkalization

SPL UNCLASSIFIED SECTION

Usual Adult Dose

SPL UNCLASSIFIED SECTION

2 to 6 teaspoonfuls (10 to 30 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician.

Usual Pediatric Dose

SPL UNCLASSIFIED SECTION

1 to 3 teaspoonfuls (5 to 15 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician. For children under two years of age, use is based on consultation with a physician.

As a neutralizing buffer

SPL UNCLASSIFIED SECTION

3 teaspoonfuls (15 mL), diluted with 15 mL water, taken as a single dose, or as directed by a physician.

HOW SUPPLIED

HOW SUPPLIED SECTION

Sodium Citrate and Citric Acid Oral Solution USP (colorless, grape flavor) is supplied in the following oral dosage forms:

1.5 g/1 g in 15 mL cups packaged as 100 cups (10 x 10)
NDC 60687-832-16

3 g/2 g in 30 mL cups packaged as 100 cups (10 x 10)
NDC 60687-834-76

STORAGE:

STORAGE AND HANDLING SECTION

Store at controlled room temperature, 20° to 25°C (68° to 77°F). Protect from freezing.

Rx ONLY

DO NOT USE IF SEAL IS BROKEN.

SPL UNCLASSIFIED SECTION

Distributed by:
American Health Packaging
Columbus, OH 43217

R02/24

Package/Label Display Panel – Cup Lid – 1.5 g/1 g per 15 mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1 g-1.5 g per 15 mL Sodium Citrate and Citric Acid Oral Solution Cup Lid1 g-1.5 g per 15 mL Sodium Citrate and Citric Acid Oral Solution Cup Lid

Rx Only

NDC 60687- 832-44

Sodium Citrate and
Citric Acid

ORAL SOLUTION, USP

1.5 g/1 g per 15 mL

Sugar Free

Delivers 15 mL

SHAKE WELL – DILUTE AS DIRECTED
PROTECT FROM FREEZING.

See package insert for full
prescribing information and storage.

For Institutional Use Only.

American Health Packaging
Columbus, OH 43217

F0595C150224

Package/Label Display Panel – Cup Lid – 3 g/2 g per 30 mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2 gm/3 gm per 30 mL Sodium Citrate and Citric Acid Oral Solution Cup Lid2 gm/3 gm per 30 mL Sodium Citrate and Citric Acid Oral Solution Cup Lid

Rx Only

NDC 60687- 834-45

Sodium Citrate and
Citric Acid

ORAL SOLUTION, USP

3 g/2 g per 30 mL

Sugar Free

Delivers 30 mL

SHAKE WELL – DILUTE AS DIRECTED
PROTECT FROM FREEZING.

See package insert for full
prescribing information and storage.

For Institutional Use Only.

American Health Packaging
Columbus, OH 43217

F0595C300224

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
543014citric acid 334 MG / sodium citrate 500 MG in 5 mL Oral SolutionPSN1
543014citric acid 66.8 MG/ML / sodium citrate 100 MG/ML Oral SolutionSCD1
543014citric acid 1002 MG / sodium citrate 1500 MG per 15 ML Oral SolutionSY1
543014citric acid 2004 MG / sodium citrate 3000 MG per 30 ML Oral SolutionSY1
543014citric acid 334 MG / sodium citrate 500 MG per 5 ML Oral SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60687-832-16Sodium Citrate and Citric Acid10 in 1 CASESOLUTION101
60687-832-44Sodium Citrate and Citric Acid15 mL in 1 CUP, UNIT-DOSESOLUTION151
60687-832-50Sodium Citrate and Citric Acid10 in 1 TRAYSOLUTION101
60687-834-45Sodium Citrate and Citric Acid30 mL in 1 CUP, UNIT-DOSESOLUTION301
60687-834-51Sodium Citrate and Citric Acid10 in 1 TRAYSOLUTION101
60687-834-76Sodium Citrate and Citric Acid10 in 1 CASESOLUTION101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60687-832SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE AND CITRIC ACID MONOHYDRATE) SOLUTION [AMERICAN HEALTH PACKAGING]1Current NDC, 3 package rows20240721_58fa9952-c8ab-4ebb-a073-15cc45f4832a.zip
60687-834SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE AND CITRIC ACID MONOHYDRATE) SOLUTION [AMERICAN HEALTH PACKAGING]1Current NDC, 3 package rows20240721_58fa9952-c8ab-4ebb-a073-15cc45f4832a.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60687-832-16ML - Milliliter60687-832c1045389-b61b-41f2-bf9a-f101286b5a4a12024-08-12
60687-832-44ML - Milliliter60687-832ff1522ec-1a14-4b6e-a973-d4b4fbd2a09c12024-08-12
60687-834-45ML - Milliliter60687-834886333c0-3b33-4d32-b1c0-397e6bd72efa12024-08-12
60687-834-76ML - Milliliter60687-834c7e3b8c4-fc7b-4332-9cd2-a8bb51c1733612024-08-12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60687-83260687-832-44, 60687-832-50, 60687-832-16
60687-83460687-834-45, 60687-834-51, 60687-834-76

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATEAmerican Health Packaging58fa9952-c8ab-4ebb-a073-15cc45f4832a2024-07-16Adverse reactionsExact identifier
ndc (package): 60687-834-76
ndc (package): 60687-832-16
ndc (package): 60687-832-50
ndc (package): 60687-834-45
ndc (package): 60687-832-44
ndc (package): 60687-834-51
ndc (product): 60687-834
ndc (product): 60687-832
ndc11 (package): 60687083244
ndc11 (package): 60687083476
ndc11 (package): 60687083216
ndc11 (package): 60687083445
ndc11 (package): 60687083250
ndc11 (package): 60687083451
spl id: 1d62bd0d-9703-cbc0-e063-6294a90a7eea
spl set id: 58fa9952-c8ab-4ebb-a073-15cc45f4832a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.